2002
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host a...
Online tool provides latest information about treatment options for common condition DALLAS - The American Heart Association today announced a strategic relationship with Guidant Corporation, a...
CADILLAC Trial Was Largest Interventional Trial Evaluating Heart Attack Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Additional Stent Lengths and Diameters Give Physicians Broader Treatment Options Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Results Show Efficacy in Patients Presenting with Abrupt or Threatened Abrupt Closure Indianapolis, Ind. and Santa Clara, Calif - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Defibrillation Lead Features Advances in Ease of Handling and Positioning Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
New Entity Will Identify Opportunities in Telemedicine, Clinical Informatics and Advanced Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world...
Cardica, Inc. Develops Anastomotic Devices Designed to Make Procedure Faster, Easier Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Acquisition Strategically Positions Company for Long-Term Leadership in Drug Eluting Stent Market Guidant Gains Access to Cook Group''s $500 Million Medical Technology Franchise Guidant to Hold...
Smallest, Thinnest Defibrillator Offers Advanced Rhythm Discrimination and Industry-Leading Longevity Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
MADIT II-Based Indication Provides Lifesaving Technology to Thousands of At-Risk Heart Attack Survivors Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader...
Quarterly Sales reach $807 million (+23 percent) with adjusted Net Income of $163 million (+42 percent) and Earnings Per Share of $0.53 (+41 percent) Double-digit sales and earnings growth...
New Solution Offers Fast, Effective Treatment For Common Complication After Cardiac Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2002 earnings...
Study Intended to Expand Indications for VASOVIEW Endoscopic Vessel Harvesting System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...
Relationship Advances Efforts to Increase Patient Awareness of Disease and Therapies Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
Guidant Comments on Summary Judgment Ruling in Cook-Boston Scientific Litigation Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported today that the United States District Court...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the 23rd Annual Goldman...
Six Month Follow-Up Study Shows 17.5 Percent Binary Restenosis Rate Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...
New Option Allows Early Intervention of Common Complication Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
New Platform Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Inventors of the Implantable Defibrillator Honored by the National Inventors Hall of Fame Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
DELIVER and ELUTES Data Continue to Support Benefit of Paclitaxel Eluting Stents Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...
Company to Hold Mid-Quarter Call Today Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today...